nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—CYP1A1—Clobetasol propionate—psoriasis	0.145	0.196	CbGbCtD
Menadione—MTHFR—Methotrexate—psoriasis	0.105	0.141	CbGbCtD
Menadione—CYP2A6—Methoxsalen—psoriasis	0.0892	0.12	CbGbCtD
Menadione—CYP1A1—Methoxsalen—psoriasis	0.0762	0.103	CbGbCtD
Menadione—AOX1—Methotrexate—psoriasis	0.0697	0.0939	CbGbCtD
Menadione—CYP1A2—Clobetasol propionate—psoriasis	0.0648	0.0873	CbGbCtD
Menadione—CYP1A1—Cholecalciferol—psoriasis	0.0505	0.068	CbGbCtD
Menadione—CYP2A6—Prednisolone—psoriasis	0.0434	0.0584	CbGbCtD
Menadione—CYP1A2—Methoxsalen—psoriasis	0.0341	0.0459	CbGbCtD
Menadione—CYP2A6—Dexamethasone—psoriasis	0.0256	0.0345	CbGbCtD
Menadione—CYP1A1—Dexamethasone—psoriasis	0.0219	0.0294	CbGbCtD
Menadione—BGLAP—skeletal joint—psoriasis	0.021	0.213	CbGeAlD
Menadione—CYP2E1—Dexamethasone—psoriasis	0.0169	0.0227	CbGbCtD
Menadione—BGLAP—vertebral column—psoriasis	0.0167	0.169	CbGeAlD
Menadione—F7—endothelium—psoriasis	0.0127	0.129	CbGeAlD
Menadione—F9—endothelium—psoriasis	0.0122	0.123	CbGeAlD
Menadione—F2—vertebral column—psoriasis	0.0104	0.105	CbGeAlD
Menadione—Thalidomide—NFKB1—psoriasis	0.0065	0.765	CrCbGaD
Menadione—F2—endothelium—psoriasis	0.00463	0.0468	CbGeAlD
Menadione—VKORC1L1—tendon—psoriasis	0.0039	0.0395	CbGeAlD
Menadione—CYP1A1—skin epidermis—psoriasis	0.00264	0.0267	CbGeAlD
Menadione—GGCX—tendon—psoriasis	0.00236	0.0239	CbGeAlD
Menadione—PROS1—tendon—psoriasis	0.00224	0.0227	CbGeAlD
Menadione—F10—tendon—psoriasis	0.00211	0.0214	CbGeAlD
Menadione—Thalidomide—TNF—psoriasis	0.00199	0.235	CrCbGaD
Menadione—NQO1—skin of body—psoriasis	0.00165	0.0167	CbGeAlD
Menadione—NQO2—tendon—psoriasis	0.0015	0.0152	CbGeAlD
Menadione—NQO1—tendon—psoriasis	0.00125	0.0127	CbGeAlD
Menadione—AOX1—tendon—psoriasis	0.00115	0.0116	CbGeAlD
Menadione—MAOB—tendon—psoriasis	0.000887	0.00897	CbGeAlD
Menadione—CYP1A1—skin of body—psoriasis	0.000818	0.00828	CbGeAlD
Menadione—CYP2E1—tendon—psoriasis	0.000568	0.00575	CbGeAlD
Menadione—XDH—Selenium Micronutrient Network—IFNG—psoriasis	0.000229	0.00152	CbGpPWpGaD
Menadione—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000229	0.00152	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—ICAM1—psoriasis	0.000228	0.00152	CbGpPWpGaD
Menadione—PROS1—Immune System—ERAP1—psoriasis	0.000228	0.00152	CbGpPWpGaD
Menadione—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000227	0.00151	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HLA-C—psoriasis	0.000225	0.0015	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000224	0.00149	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—JUN—psoriasis	0.000223	0.00148	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—TNFAIP3—psoriasis	0.000222	0.00148	CbGpPWpGaD
Menadione—F10—Hemostasis—ITGAL—psoriasis	0.000221	0.00147	CbGpPWpGaD
Menadione—F2—Folate Metabolism—IFNG—psoriasis	0.000219	0.00145	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—ACE—psoriasis	0.000218	0.00145	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000217	0.00144	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—NFKB1—psoriasis	0.00021	0.0014	CbGpPWpGaD
Menadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000209	0.00139	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TNF—psoriasis	0.000206	0.00137	CbGpPWpGaD
Menadione—MTHFR—Vitamin B12 Metabolism—IL6—psoriasis	0.000204	0.00136	CbGpPWpGaD
Menadione—PROS1—Immune System—DDX58—psoriasis	0.000201	0.00133	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000198	0.00132	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—LEP—psoriasis	0.000198	0.00131	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—REN—psoriasis	0.000198	0.00131	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—ACE—psoriasis	0.000195	0.00129	CbGpPWpGaD
Menadione—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000192	0.00128	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—NFKB1—psoriasis	0.000191	0.00127	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000188	0.00125	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HLA-E—psoriasis	0.000187	0.00124	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000185	0.00123	CbGpPWpGaD
Menadione—F9—Hemostasis—NOS2—psoriasis	0.000183	0.00122	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—ACE—psoriasis	0.000183	0.00122	CbGpPWpGaD
Menadione—F2—Folate Metabolism—NFKB1—psoriasis	0.000182	0.00121	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TP53—psoriasis	0.000181	0.0012	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000181	0.0012	CbGpPWpGaD
Menadione—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00018	0.0012	CbGpPWpGaD
Menadione—NQO1—Metabolism—NDUFA5—psoriasis	0.00018	0.0012	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HCAR2—psoriasis	0.00018	0.00119	CbGpPWpGaD
Menadione—MTHFR—Metabolism—NDUFA5—psoriasis	0.000178	0.00118	CbGpPWpGaD
Menadione—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.000177	0.00117	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—TNF—psoriasis	0.000174	0.00116	CbGpPWpGaD
Menadione—AOX1—Metabolism—NDUFA5—psoriasis	0.000174	0.00116	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—IFNG—psoriasis	0.000174	0.00115	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000169	0.00112	CbGpPWpGaD
Menadione—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000167	0.00111	CbGpPWpGaD
Menadione—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000167	0.00111	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—IL6—psoriasis	0.000166	0.0011	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—CCL20—psoriasis	0.000165	0.0011	CbGpPWpGaD
Menadione—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000164	0.00109	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—TNF—psoriasis	0.000163	0.00109	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HCAR2—psoriasis	0.000163	0.00108	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—ACE—psoriasis	0.000162	0.00108	CbGpPWpGaD
Menadione—XDH—Metabolism—NDUFA5—psoriasis	0.000162	0.00107	CbGpPWpGaD
Menadione—F7—Hemostasis—NOS2—psoriasis	0.000161	0.00107	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—SOCS1—psoriasis	0.000156	0.00104	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—LEP—psoriasis	0.000154	0.00103	CbGpPWpGaD
Menadione—NQO1—Metabolism—CYP2S1—psoriasis	0.000153	0.00102	CbGpPWpGaD
Menadione—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000153	0.00102	CbGpPWpGaD
Menadione—PROS1—Immune System—ITGAL—psoriasis	0.000152	0.00101	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CYP2S1—psoriasis	0.000151	0.00101	CbGpPWpGaD
Menadione—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000149	0.000989	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—TNF—psoriasis	0.000148	0.000986	CbGpPWpGaD
Menadione—AOX1—Metabolism—CYP2S1—psoriasis	0.000148	0.000983	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TP53—psoriasis	0.000147	0.000978	CbGpPWpGaD
Menadione—MAOB—Metabolism—NDUFA5—psoriasis	0.000147	0.000976	CbGpPWpGaD
Menadione—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000146	0.000969	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—LEP—psoriasis	0.000146	0.000969	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—NFKB1—psoriasis	0.000145	0.000961	CbGpPWpGaD
Menadione—PROS1—Immune System—REL—psoriasis	0.000142	0.000946	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TNF—psoriasis	0.000142	0.00094	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—IL6—psoriasis	0.00014	0.000933	CbGpPWpGaD
Menadione—PROS1—Immune System—IFIH1—psoriasis	0.000138	0.000919	CbGpPWpGaD
Menadione—XDH—Metabolism—CYP2S1—psoriasis	0.000137	0.000914	CbGpPWpGaD
Menadione—F2—Hemostasis—ITGAL—psoriasis	0.000136	0.000905	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—LEP—psoriasis	0.000136	0.000901	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—IL6—psoriasis	0.000135	0.000895	CbGpPWpGaD
Menadione—PROC—Hemostasis—NOS2—psoriasis	0.000135	0.000894	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000134	0.000889	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HLA-B—psoriasis	0.000133	0.000884	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—IL6—psoriasis	0.000132	0.000876	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—CXCL8—psoriasis	0.000131	0.000874	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-C—psoriasis	0.000131	0.000871	CbGpPWpGaD
Menadione—PROS1—Immune System—TNFAIP3—psoriasis	0.000129	0.00086	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000127	0.000844	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000127	0.000843	CbGpPWpGaD
Menadione—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000126	0.000836	CbGpPWpGaD
Menadione—MAOB—Metabolism—CYP2S1—psoriasis	0.000125	0.00083	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000125	0.00083	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TP53—psoriasis	0.000125	0.000829	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—ACE—psoriasis	0.000123	0.00082	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—REN—psoriasis	0.000122	0.000809	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—LEP—psoriasis	0.000121	0.000803	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—IL6—psoriasis	0.00012	0.000796	CbGpPWpGaD
Menadione—PROS1—Hemostasis—NOS2—psoriasis	0.000119	0.000792	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—CRP—psoriasis	0.000118	0.000781	CbGpPWpGaD
Menadione—F2—Folate Metabolism—IL6—psoriasis	0.000114	0.000759	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—LEP—psoriasis	0.000114	0.000755	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—TNF—psoriasis	0.000112	0.000747	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.00011	0.00073	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-E—psoriasis	0.000109	0.000723	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—NFKBIA—psoriasis	0.000107	0.000713	CbGpPWpGaD
Menadione—F9—Hemostasis—VEGFA—psoriasis	0.000106	0.000704	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000106	0.000702	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—CXCL8—psoriasis	0.000103	0.000682	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—LEP—psoriasis	0.000101	0.000668	CbGpPWpGaD
Menadione—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	9.75e-05	0.000648	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—CXCL8—psoriasis	9.69e-05	0.000644	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HCAR2—psoriasis	9.63e-05	0.00064	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	9.6e-05	0.000638	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—CCL20—psoriasis	9.33e-05	0.00062	CbGpPWpGaD
Menadione—F7—Hemostasis—VEGFA—psoriasis	9.3e-05	0.000618	CbGpPWpGaD
Menadione—PROS1—Immune System—SOCS1—psoriasis	9.08e-05	0.000604	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	9.08e-05	0.000603	CbGpPWpGaD
Menadione—F10—Hemostasis—NOS2—psoriasis	9.08e-05	0.000603	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—IL6—psoriasis	9.07e-05	0.000603	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—CXCL8—psoriasis	9.01e-05	0.000599	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—TYK2—psoriasis	8.78e-05	0.000584	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—CXCL8—psoriasis	8.73e-05	0.00058	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CCL20—psoriasis	8.47e-05	0.000563	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TAGAP—psoriasis	8.35e-05	0.000555	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	8.22e-05	0.000546	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	8.22e-05	0.000546	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	8.1e-05	0.000538	CbGpPWpGaD
Menadione—PROS1—Immune System—CD8A—psoriasis	8.06e-05	0.000535	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—CXCL8—psoriasis	8.03e-05	0.000534	CbGpPWpGaD
Menadione—F9—Hemostasis—TP53—psoriasis	8.01e-05	0.000532	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—CD4—psoriasis	7.94e-05	0.000528	CbGpPWpGaD
Menadione—PROC—Hemostasis—VEGFA—psoriasis	7.8e-05	0.000518	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-B—psoriasis	7.75e-05	0.000515	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	7.71e-05	0.000512	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—LEP—psoriasis	7.66e-05	0.000509	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—ACE—psoriasis	7.6e-05	0.000505	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—CXCL8—psoriasis	7.55e-05	0.000502	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	7.55e-05	0.000501	CbGpPWpGaD
Menadione—NQO1—Metabolism—CARM1—psoriasis	7.49e-05	0.000497	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CARM1—psoriasis	7.39e-05	0.000491	CbGpPWpGaD
Menadione—AOX1—Metabolism—CARM1—psoriasis	7.22e-05	0.00048	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-A—psoriasis	7.18e-05	0.000477	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—NDUFA5—psoriasis	7.16e-05	0.000476	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—JUN—psoriasis	7.11e-05	0.000472	CbGpPWpGaD
Menadione—F7—Hemostasis—TP53—psoriasis	7.03e-05	0.000467	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	7e-05	0.000465	CbGpPWpGaD
Menadione—PROS1—Hemostasis—VEGFA—psoriasis	6.9e-05	0.000458	CbGpPWpGaD
Menadione—PROS1—Immune System—CRP—psoriasis	6.85e-05	0.000455	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—NFKB1—psoriasis	6.84e-05	0.000455	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.74e-05	0.000448	CbGpPWpGaD
Menadione—XDH—Metabolism—CARM1—psoriasis	6.71e-05	0.000446	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—CXCL8—psoriasis	6.68e-05	0.000444	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DRB1—psoriasis	6.56e-05	0.000436	CbGpPWpGaD
Menadione—PROS1—Immune System—ICAM1—psoriasis	6.3e-05	0.000418	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.28e-05	0.000417	CbGpPWpGaD
Menadione—PROS1—Immune System—NFKBIA—psoriasis	6.25e-05	0.000415	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.12e-05	0.000407	CbGpPWpGaD
Menadione—MAOB—Metabolism—CARM1—psoriasis	6.1e-05	0.000405	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP2S1—psoriasis	6.09e-05	0.000404	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—psoriasis	5.89e-05	0.000391	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	5.85e-05	0.000389	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NDUFA5—psoriasis	5.66e-05	0.000376	CbGpPWpGaD
Menadione—F2—Hemostasis—NOS2—psoriasis	5.59e-05	0.000371	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NDUFA5—psoriasis	5.33e-05	0.000354	CbGpPWpGaD
Menadione—F10—Hemostasis—VEGFA—psoriasis	5.26e-05	0.000349	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.24e-05	0.000348	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.24e-05	0.000348	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—psoriasis	5.21e-05	0.000346	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	5.2e-05	0.000345	CbGpPWpGaD
Menadione—PROS1—Immune System—TYK2—psoriasis	5.12e-05	0.00034	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—CXCL8—psoriasis	5.09e-05	0.000338	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCL20—psoriasis	5e-05	0.000332	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.97e-05	0.00033	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP2S1—psoriasis	4.81e-05	0.00032	CbGpPWpGaD
Menadione—PROS1—Immune System—IFNG—psoriasis	4.79e-05	0.000318	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—LEP—psoriasis	4.72e-05	0.000314	CbGpPWpGaD
Menadione—PROS1—Immune System—CD4—psoriasis	4.63e-05	0.000307	CbGpPWpGaD
Menadione—NQO1—Metabolism—CAT—psoriasis	4.6e-05	0.000306	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CAT—psoriasis	4.55e-05	0.000302	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP2S1—psoriasis	4.54e-05	0.000301	CbGpPWpGaD
Menadione—MTHFR—Disease—HLA-A—psoriasis	4.52e-05	0.0003	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—CXCL8—psoriasis	4.46e-05	0.000296	CbGpPWpGaD
Menadione—AOX1—Metabolism—CAT—psoriasis	4.44e-05	0.000295	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	4.44e-05	0.000295	CbGpPWpGaD
Menadione—AOX1—Disease—HLA-A—psoriasis	4.42e-05	0.000293	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—IL6—psoriasis	4.3e-05	0.000285	CbGpPWpGaD
Menadione—MTHFR—Disease—APOE—psoriasis	4.22e-05	0.00028	CbGpPWpGaD
Menadione—PROS1—Immune System—JUN—psoriasis	4.14e-05	0.000275	CbGpPWpGaD
Menadione—XDH—Metabolism—CAT—psoriasis	4.13e-05	0.000274	CbGpPWpGaD
Menadione—AOX1—Disease—APOE—psoriasis	4.12e-05	0.000274	CbGpPWpGaD
Menadione—PROS1—Immune System—NFKB1—psoriasis	3.99e-05	0.000265	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—psoriasis	3.97e-05	0.000264	CbGpPWpGaD
Menadione—MTHFR—Disease—NOS2—psoriasis	3.93e-05	0.000261	CbGpPWpGaD
Menadione—AOX1—Disease—NOS2—psoriasis	3.84e-05	0.000255	CbGpPWpGaD
Menadione—MAOB—Metabolism—CAT—psoriasis	3.75e-05	0.000249	CbGpPWpGaD
Menadione—PROS1—Immune System—STAT3—psoriasis	3.58e-05	0.000238	CbGpPWpGaD
Menadione—NQO1—Metabolism—APOE—psoriasis	3.58e-05	0.000238	CbGpPWpGaD
Menadione—MTHFR—Metabolism—APOE—psoriasis	3.53e-05	0.000235	CbGpPWpGaD
Menadione—AOX1—Metabolism—APOE—psoriasis	3.45e-05	0.000229	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NDUFA5—psoriasis	3.4e-05	0.000226	CbGpPWpGaD
Menadione—F2—Hemostasis—VEGFA—psoriasis	3.24e-05	0.000215	CbGpPWpGaD
Menadione—MTHFR—Disease—TYK2—psoriasis	3.22e-05	0.000214	CbGpPWpGaD
Menadione—XDH—Metabolism—APOE—psoriasis	3.21e-05	0.000213	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.17e-05	0.000211	CbGpPWpGaD
Menadione—AOX1—Disease—TYK2—psoriasis	3.15e-05	0.000209	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CXCL8—psoriasis	3.14e-05	0.000208	CbGpPWpGaD
Menadione—NQO1—Metabolism—PPARG—psoriasis	3.12e-05	0.000207	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PPARG—psoriasis	3.08e-05	0.000205	CbGpPWpGaD
Menadione—AOX1—Metabolism—PPARG—psoriasis	3.01e-05	0.0002	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CARM1—psoriasis	2.97e-05	0.000198	CbGpPWpGaD
Menadione—MAOB—Metabolism—APOE—psoriasis	2.92e-05	0.000194	CbGpPWpGaD
Menadione—MTHFR—Disease—CD4—psoriasis	2.91e-05	0.000194	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP2S1—psoriasis	2.89e-05	0.000192	CbGpPWpGaD
Menadione—AOX1—Disease—CD4—psoriasis	2.85e-05	0.000189	CbGpPWpGaD
Menadione—XDH—Metabolism—PPARG—psoriasis	2.8e-05	0.000186	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SOCS1—psoriasis	2.76e-05	0.000183	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—TYK2—psoriasis	2.63e-05	0.000175	CbGpPWpGaD
Menadione—MAOB—Metabolism—PPARG—psoriasis	2.54e-05	0.000169	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—CXCL8—psoriasis	2.52e-05	0.000167	CbGpPWpGaD
Menadione—PROS1—Immune System—IL6—psoriasis	2.5e-05	0.000166	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—psoriasis	2.45e-05	0.000163	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.38e-05	0.000158	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CARM1—psoriasis	2.35e-05	0.000156	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CXCL8—psoriasis	2.29e-05	0.000152	CbGpPWpGaD
Menadione—MTHFR—Disease—STAT3—psoriasis	2.26e-05	0.00015	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CARM1—psoriasis	2.22e-05	0.000147	CbGpPWpGaD
Menadione—AOX1—Disease—STAT3—psoriasis	2.2e-05	0.000146	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.07e-05	0.000138	CbGpPWpGaD
Menadione—F2—Signaling Pathways—APOE—psoriasis	2.03e-05	0.000135	CbGpPWpGaD
Menadione—F2—Signaling Pathways—LEP—psoriasis	2.03e-05	0.000135	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NFKBIA—psoriasis	1.9e-05	0.000126	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CAT—psoriasis	1.83e-05	0.000121	CbGpPWpGaD
Menadione—MTHFR—Disease—IL6—psoriasis	1.58e-05	0.000105	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TYK2—psoriasis	1.55e-05	0.000103	CbGpPWpGaD
Menadione—AOX1—Disease—IL6—psoriasis	1.54e-05	0.000102	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.52e-05	0.000101	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CAT—psoriasis	1.45e-05	9.6e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—APOE—psoriasis	1.42e-05	9.44e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CARM1—psoriasis	1.41e-05	9.38e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CAT—psoriasis	1.36e-05	9.05e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CXCL8—psoriasis	1.35e-05	8.98e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.32e-05	8.77e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL6—psoriasis	1.29e-05	8.54e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—JUN—psoriasis	1.26e-05	8.35e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PPARG—psoriasis	1.24e-05	8.22e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NFKB1—psoriasis	1.21e-05	8.04e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—APOE—psoriasis	1.12e-05	7.46e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—VEGFA—psoriasis	1.1e-05	7.29e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—STAT3—psoriasis	1.09e-05	7.22e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—APOE—psoriasis	1.06e-05	7.03e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PPARG—psoriasis	9.78e-06	6.5e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PPARG—psoriasis	9.22e-06	6.13e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CAT—psoriasis	8.69e-06	5.77e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—psoriasis	8.29e-06	5.51e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6—psoriasis	7.59e-06	5.04e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—APOE—psoriasis	6.75e-06	4.48e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PPARG—psoriasis	5.88e-06	3.91e-05	CbGpPWpGaD
